How Much Did InterCure Raise?
Funding & Key Investors

InterCure, the prominent international cannabis enterprise, has successfully secured a major strategic investment, bringing its total capital accumulation to $11M. This latest infusion of $11M underscores the firm's robust market position and its capacity to scale operations within the highly regulated pharmaceutical-grade medical cannabis sector. By leveraging its established infrastructure, the company continues to solidify its footprint as a dominant force in the global medicinal cannabis landscape.

What is InterCure?

InterCure
ManufacturingPharmaceuticalsDrug Stores & Pharmacies

InterCure, operating through its wholly owned subsidiary Canndoc, functions as a premier vertically integrated cannabis entity. As the largest licensed producer in Israel, the company distinguishes itself through strict adherence to Good Manufacturing Practices (GMP), ensuring that its pharmaceutical-grade products meet rigorous international standards. The firm utilizes a comprehensive seed-to-sale model, which encompasses cultivation, processing, and a sophisticated distribution network. This strategic framework allows InterCure to maintain high-margin operations while effectively navigating the complex regulatory environments inherent to the medical cannabis industry. By securing international partnerships, the company has successfully transitioned from a regional leader to a significant player in the global market, setting a benchmark for quality and operational excellence in the cannabis sector.

How much funding has InterCure raised?

InterCure has raised a total of $11M across 1 funding round:

2020

Share Placement

$11M

Share Placement (2020): $11M, investors not publicly disclosed

Key Investors in InterCure

Undisclosed Investor

An undisclosed institutional investor participating in the strategic financing round to support the company's global expansion objectives.

What's next for InterCure?

With the recent injection of capital, InterCure is well-positioned to accelerate its international expansion strategy. The company is expected to focus on scaling its production capacity and enhancing its distribution capabilities to meet the rising global demand for standardized medical cannabis. Future growth initiatives will likely involve deepening its existing international partnerships and exploring new markets where pharmaceutical-grade cannabis is gaining regulatory approval. By maintaining its focus on high-margin, vertically integrated operations, InterCure aims to sustain its competitive advantage and drive long-term value for stakeholders as it continues to professionalize the medical cannabis supply chain on a global scale.

See full InterCure company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

Industrial Machinery & EquipmentManufacturingCleaning Products
Food & BeverageManufacturing
Industrial Machinery & EquipmentManufacturing
Industrial Machinery & EquipmentManufacturingAutomotive Parts

Frequently Asked Questions Regarding InterCure Financial Insights

What are the most recent funding rounds that InterCure has completed, and what were the funding rounds?
InterCure has recently completed 1 funding rounds: Share Placement on Jun 11, 2020.
What is the total amount of funding InterCure has raised to date?
InterCure has raised a total of $11M in funding to date.
How many funding rounds has InterCure completed?
InterCure has completed 1 funding rounds.
How much funding did InterCure raise in its most recent funding round?
InterCure raised $11M in its most recent funding round.
Which was the largest funding round in InterCure's history?
The largest funding round in InterCure's history was $11M.
See more information about InterCure